Healthcare provider profile · identity verified

Michael L Gee

Allopathic & Osteopathic Physicians|Internal Medicine · THOMASVILLE, GA · NPI 1992774376

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Michael L Gee received $62.91 in general payments during 2025 across 3 reported records.

Gilead Sciences, Inc. accounted for 46.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus, Trelegy Ellipta.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Arexvy by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Shingrix by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 44 claims for Trelegy Ellipta by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 113 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$62.91

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Gilead Sciences, Inc.	Unresolved — no canonical attribution shown	$29.43	46.8%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.36	29.2%	1	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$15.12	24.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$62.91	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$18.36	1	2025
Source payment records 2025-02-19 · Novo Nordisk Inc · $18.36 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$18.36	1	2025
Source payment records 2025-02-19 · Novo Nordisk Inc · $18.36 · Open Payments source
TRELEGY ELLIPTA Normalized: trelegy ellipta	Drug	GlaxoSmithKline, LLC.	$15.12	1	2025
Source payment records 2025-02-03 · GlaxoSmithKline, LLC. · $15.12 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	113	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	17 Beneficiary count suppressed	exact normalized	Medicare Part D
TRELEGY ELLIPTA trelegy ellipta	2025	Trelegy Ellipta	2024	44 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	AREXVY open payments reported associated product	CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445	Arexvy · 2024 Exact normalized brand match · 1 Part D row	91	91
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	SHINGRIX open payments reported associated product	CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452	Shingrix · 2024 Exact normalized brand match · 1 Part D row	32	26
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	44	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	113	18
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	878	250
Levothyroxine Sodium	Levothyroxine Sodium	595	143
Amlodipine Besylate	Amlodipine Besylate	588	163
Omeprazole	Omeprazole	434	116
Alprazolam	Alprazolam	398	79
Lisinopril	Lisinopril	398	117
Metoprolol Succinate	Metoprolol Succinate	389	104
Losartan Potassium	Losartan Potassium	355	93
Simvastatin	Simvastatin	327	83
Pantoprazole Sodium	Pantoprazole Sodium	323	89
Zolpidem Tartrate	Zolpidem Tartrate	303	73
Eliquis	Apixaban	261	46
Tramadol Hcl	Tramadol Hcl	255	84
Hydrochlorothiazide	Hydrochlorothiazide	250	67
Metformin Hcl	Metformin Hcl	244	74
Escitalopram Oxalate	Escitalopram Oxalate	238	64
Furosemide	Furosemide	232	84
Farxiga	Dapagliflozin Propanediol	190	43
Meloxicam	Meloxicam	186	59
Metoprolol Tartrate	Metoprolol Tartrate	176	46
Trazodone Hcl	Trazodone Hcl	172	49
Tamsulosin Hcl	Tamsulosin Hcl	171	52
Citalopram Hbr	Citalopram Hydrobromide	155	36
Rosuvastatin Calcium	Rosuvastatin Calcium	151	47
Gabapentin	Gabapentin	149	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	146	34
Montelukast Sodium	Montelukast Sodium	144	39
Famotidine	Famotidine	142	38
Potassium Chloride	Potassium Chloride	142	49
Atenolol	Atenolol	139	36
Clonazepam	Clonazepam	136	26
Prednisone	Prednisone	134	93
Alendronate Sodium	Alendronate Sodium	126	35
Estradiol	Estradiol	119	27
Venlafaxine Hcl Er	Venlafaxine Hcl	119	25
Albuterol Sulfate Hfa	Albuterol Sulfate	117	41
Clopidogrel	Clopidogrel Bisulfate	116	33
Ezetimibe	Ezetimibe	115	33
Ozempic	Semaglutide	113	18
Pravastatin Sodium	Pravastatin Sodium	113	33
Fluticasone Propionate	Fluticasone Propionate	110	33
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	108	86
Allopurinol	Allopurinol	107	32
Jardiance	Empagliflozin	104	21
Hydralazine Hcl	Hydralazine Hcl	98	22
Ropinirole Hcl	Ropinirole Hcl	98	20
Tizanidine Hcl	Tizanidine Hcl	98	36
Glimepiride	Glimepiride	97	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	93	68
Sertraline Hcl	Sertraline Hcl	92	24
Arexvy	Rsvpref3 Antigen/As01e/Pf	91	91
Pioglitazone Hcl	Pioglitazone Hcl	91	33
Spironolactone	Spironolactone	82	27
Carvedilol	Carvedilol	78	26
Duloxetine Hcl	Duloxetine Hcl	78	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	22
Bupropion Xl	Bupropion Hcl	74	22
Finasteride	Finasteride	70	20
Torsemide	Torsemide	70	19
Donepezil Hcl	Donepezil Hcl	69	17
Synthroid	Levothyroxine Sodium	68	13
Memantine Hcl	Memantine Hcl	64	13
Pregabalin	Pregabalin	62	14
Tresiba Flextouch U-100	Insulin Degludec	61	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	56
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	59	17
Lorazepam	Lorazepam	59	23
Methylprednisolone	Methylprednisolone	59	54
Valsartan	Valsartan	59	14
Buspirone Hcl	Buspirone Hcl	55	13
Entresto	Sacubitril/Valsartan	52	suppressed
Nifedipine Er	Nifedipine	52	15
Oxybutynin Chloride Er	Oxybutynin Chloride	52	19
Amitriptyline Hcl	Amitriptyline Hcl	49	suppressed
Lovastatin	Lovastatin	48	13
Diclofenac Sodium	Diclofenac Sodium	47	16
Chlorthalidone	Chlorthalidone	46	13
Januvia	Sitagliptin Phosphate	46	11
Amoxicillin	Amoxicillin	45	41
Ondansetron Hcl	Ondansetron Hcl	45	32
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Benazepril Hcl	Benazepril Hcl	44	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Bupropion Hcl Sr	Bupropion Hcl	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Mounjaro	Tirzepatide	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	16
Nortriptyline Hcl	Nortriptyline Hcl	38	11
Doxazosin Mesylate	Doxazosin Mesylate	37	11
Xarelto	Rivaroxaban	37	suppressed
Celecoxib	Celecoxib	36	11
Clonidine Hcl	Clonidine Hcl	36	suppressed
Tradjenta	Linagliptin	36	suppressed
Cefdinir	Cefdinir	35	35
Cholestyramine	Cholestyramine (With Sugar)	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Bumetanide	Bumetanide	33	suppressed
Fluconazole	Fluconazole	33	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	30
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	26
Valacyclovir	Valacyclovir Hcl	32	17
Diazepam	Diazepam	31	suppressed
Levofloxacin	Levofloxacin	31	29
Linzess	Linaclotide	31	suppressed
Premarin	Estrogens, Conjugated	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Hydrocortisone	Hydrocortisone	30	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	23
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Fenofibrate	Fenofibrate,micronized	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	17
Meclizine Hcl	Meclizine Hcl	27	16
Ondansetron Odt	Ondansetron	26	suppressed
Testosterone	Testosterone	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Mupirocin	Mupirocin	25	21
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Repatha Sureclick	Evolocumab	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Primidone	Primidone	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Potassium Citrate Er	Potassium Citrate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	18	18
Colchicine	Colchicine	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	12
Gemfibrozil	Gemfibrozil	18	suppressed
Lactulose	Lactulose	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Metolazone	Metolazone	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Crestor	Rosuvastatin Calcium	17	suppressed
Livalo	Pitavastatin Calcium	17	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	15
Ranolazine Er	Ranolazine	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ketoconazole	Ketoconazole	15	12
Calcitriol	Calcitriol	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Exelon	Rivastigmine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Mitigare	Colchicine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Norvasc	Amlodipine Besylate	11	suppressed
Nystatin	Nystatin	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Promethazine Hcl	Promethazine Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$62.91 · 3 records	Gilead Sciences, Inc.	Ozempic, Rybelsus, TRELEGY ELLIPTA	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error